Materna Medical announced the successful close of its $5 million B3 financing round, positioning the company for a year of clinical, commercial, and operational advancement. The round was led by InnovaHealth Partners, Wavemaker360 Health, and Band of Angels, with support from existing investors.
EliseAI, the AI company automating complex housing and healthcare systems, announced it passed $200 million in annual recurring revenue (ARR), achieving 100% year-over-year growth for the fifth consecutive year.
Oculogica, a pioneer in the development of non-invasive tests for concussion, announced the FDA has granted a 510(k) clearance for SNAP. SNAP is a 90-second concussion test that combines eye tracking with symptom severity to provide a multi-modal concussion assessment for clinicians.
Zenflow, Inc. presented data from its BREEZE pivotal clinical trial demonstrating the efficacy and safety of the Zenflow Spring Implant & Delivery System, which was FDA approved in Dec. 2025 for the treatment of symptoms associated with benign prostatic hyperplasia, also known as enlarged prostate.
Virginia Klausmeier founded Sylvatex — a California-based company with a single, audacious goal: to make the cathode better, cleaner, and cheaper than China, on American soil, using nature's own chemistry as the blueprint.
Osteoboost, the first FDA-cleared drug-free prescription treatment for osteopenia in postmenopausal women, was featured in the May edition of Vogue. May is Osteoporosis Awareness Month and Women's Health Month.
Tot Squad, a platform that supports new parents from registry through early parenthood, has acquired Robyn, a maternal health startup with an AI-powered doula trained on over 70,000 de-identified messages between real doulas and parents.
Sustainable ready-to-wear brand Another Tomorrow hosted its third "New Earth Dialogues" installment with architect Lindsey Wikstrom—founding principal of Mattaforma and recent recipient of the Cooper Hewitt National Design Award—to discuss.
Chromatic 3D Materials announced successful prototype printing and static fire testing of its additively manufactured rocket propellant. The tests demonstrated that Chromatic's printed propellant can sustain combustion pressures beyond 1800 psi without structural failure, a critical milestone.
Bairitone Health has received Breakthrough Device Designation from the US Food and Drug Administration (FDA) for its sleep sonar for anatomic polysomnography technology to pinpoint the root cause of airway obstruction in people with obstructive sleep apnea (OSA).
Two Golden Seeds companies, Kind Designs and BMI OrganBank, named as winners of the 2026 Villalobos Award by the Angel Capital Association (ACA). This award recognizes the most innovative ideas financed by members of the ACA across two categories: Technology/Services/Consumer and Life Sciences.
Forbes' annual AI 50 list spotlights the most promising privately-held AI companies in the world. Under the leadership of CEO Minna Song, EliseAI continues to scale its AI platform, transforming operations across housing and healthcare, driving efficiency, automation, and better experiences.
Osteoboost Health has closed an $8 million financing round to scale manufacturing, expand clinical research, and broaden commercial reach for its FDA-cleared prescription wearable for low bone density. The round was led by Ambit Health Ventures.
Saladax Biomedical, Inc., a leader in therapeutic drug monitoring (TDM) diagnostics for psychiatry and oncology, announced a distribution agreement with Thermo Fisher Scientific to expand global access to high-quality TDM assays that help clinicians optimize patient outcomes.
.png){kind=logo}
Joylux today announced the launch of reliefHER, a proprietary vaginal hydration melt formulated with 15 mg of hyaluronic acid (HA), up to three times the HA power found in many other products.
Alcatraz, which makes an AI-powered physical access control system that authenticates employees without collecting personal data, has closed a $50 million Series B funding round, bringing total capital raised to more than $100 million.
MedOne and Nanodropper, a leader in precision medication delivery solutions, recently announced early results from the MediSplit program, a value-based clinical care path designed to improve medication adherence and reduce side effects for patients using prescription eye drops.
Madorra, a medical device company, has enrolled the first patient in its pivotal clinical trial evaluating the Madorra Therapy System for moderate to severe vulvovaginal atrophy - a milestone following the FDA's grant of Breakthrough Device Designation.
Chippin, Inc., a company that leverages planet-friendly ingredients and invasive species to create sustainable pet nutrition, has received a $1 million grant through the Meat and Poultry Processing Expansion Program to create a new market for invasive catfish in pet nutrition.
Hemex Health, a medical diagnostics company focused on decentralized testing for blood-based conditions, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to its Gazelle® Hb Variant Test.
Nanodropper announced results from a randomized clinical trial demonstrating that microvolume eyedrop delivery using their adaptor achieved greater intraocular pressure reduction, fewer adverse effects, and significantly reduced premature bottle exhaustion compared with conventional eyedrops.